source: 2026-02-17-compass-pathways-comp006-psilocybin-phase3-trd-second.md → null-result

Pentagon-Agent: Epimetheus <PIPELINE>
This commit is contained in:
Teleo Agents 2026-05-10 04:34:25 +00:00
parent a4c0e67d36
commit 60b7a0269c

View file

@ -7,10 +7,11 @@ date: 2026-02-17
domain: health domain: health
secondary_domains: [] secondary_domains: []
format: press-release format: press-release
status: unprocessed status: null-result
priority: high priority: high
tags: [psilocybin, treatment-resistant-depression, Phase-3, clinical-trial, mental-health, psychedelic-therapy, FDA, NDA, Compass-Pathways] tags: [psilocybin, treatment-resistant-depression, Phase-3, clinical-trial, mental-health, psychedelic-therapy, FDA, NDA, Compass-Pathways]
intake_tier: research-task intake_tier: research-task
extraction_model: "anthropic/claude-sonnet-4.5"
--- ---
## Content ## Content